Get the Stockscreener App
4.14
2.22%
0.09
After Hours:
4.11
-0.03
-0.72%
Precigen Inc stock is traded at $4.14, with a volume of 6.40M.
It is up +2.22% in the last 24 hours and up +25.84% over the past month.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
See More
Previous Close:
$4.05
Open:
$4.04
24h Volume:
6.40M
Relative Volume:
0.71
Market Cap:
$1.23B
Revenue:
$6.23M
Net Income/Loss:
$-95.90M
P/E Ratio:
-10.62
EPS:
-0.39
Net Cash Flow:
$-68.47M
1W Performance:
-4.39%
1M Performance:
+25.84%
6M Performance:
+165.38%
1Y Performance:
+425.25%
1-Day Range:
$3.95
$4.15
1-Week Range:
$3.93
$4.42
52-Week Range:
$0.6513
$5.225
Precigen Inc Stock (PGEN) Company Profile
Name
Precigen Inc
Sector
Industry
Phone
301-556-9900
Address
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.14 | 1.43B | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-22-24 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Initiated | JP Morgan | Neutral |
| Nov-18-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-25-21 | Initiated | Stifel | Buy |
| Feb-22-21 | Initiated | Wells Fargo | Overweight |
| Feb-18-21 | Initiated | B. Riley Securities | Buy |
| May-08-20 | Initiated | H.C. Wainwright | Buy |
View All
Precigen Inc Stock (PGEN) Latest News
Will Precigen Inc. stock gain from lower inflation2025 Fundamental Recap & Risk Controlled Stock Alerts - newser.com
Can Precigen Inc. stock outperform in 2025 bull marketTrade Entry Report & Safe Entry Trade Signal Reports - newser.com
Will Precigen Inc. benefit from macro trendsQuarterly Profit Review & Technical Pattern Based Signals - newser.com
Intraday pattern recognizer results for Precigen Inc.July 2025 Reactions & Verified Swing Trading Watchlist - newser.com
What’s the recovery path for long term holders of Precigen Inc.Market Movement Recap & Consistent Profit Trade Alerts - newser.com
Is Precigen Inc. stock oversold or undervaluedJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Can you recover from losses in Precigen Inc.July 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Strategies to average down on Precigen Inc.Market Growth Report & Reliable Entry Point Trade Alerts - newser.com
Is now a turning point for Precigen Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Applying chart zones and confluence areas to Precigen Inc.Earnings Growth Report & Smart Investment Allocation Tips - newser.com
What technical models suggest about Precigen Inc.’s comeback2025 Macro Impact & Low Risk Entry Point Tips - newser.com
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - sharewise.com
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - The Motley Fool
How to integrate Precigen Inc. into portfolio analysis toolsShare Buyback & Capital Protection Trading Alerts - newser.com
Is Precigen Inc. stock near bottom after declineJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - newser.com
Real time social sentiment graph for Precigen Inc.Market Movers & Real-Time Chart Breakout Alerts - newser.com
Why Precigen Inc. stock appeals to dividend seekersWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Earnings visualization tools for Precigen Inc.2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
Tools to assess Precigen Inc.’s risk profile2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Precigen Inc Stock (PGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):